SyzOnc, LLC
- Biotech or pharma, therapeutic R&D
SyzOnc is developing revolutionary therapies for cancer patients who have no effective treatments (including sarcoma, liver cancer and pancreatic cancer). Grounded in world-class oncology and machine learning research from Penn and the Broad Institute of Harvard and MIT, we have built an AI-enabled target and therapeutics discovery platform, based on a novel class of “triple-threat” targets discovered by our founders.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}